 Home > Biochemical Engineering > Polypeptide > Cagrilintide for Sale > QSC 99% Peptides CAS 1415456-99-3 Sema Tirz Retatrutide Weight Loss Cagrilintide

QSC 99% Peptides CAS 1415456-99-3 Sema Tirz Retatrutide Weight Loss Cagrilintide buy - large image1

QSC 99% Peptides CAS 1415456-99-3 Sema Tirz Retatrutide Weight Loss Cagrilintide buy - image1

QSC 99% Peptides CAS 1415456-99-3 Sema Tirz Retatrutide Weight Loss Cagrilintide buy - image2

QSC 99% Peptides CAS 1415456-99-3 Sema Tirz Retatrutide Weight Loss Cagrilintide buy - image3

QSC 99% Peptides CAS 1415456-99-3 Sema Tirz Retatrutide Weight Loss Cagrilintide buy - image4

QSC 99% Peptides CAS 1415456-99-3 Sema Tirz Retatrutide Weight Loss Cagrilintide

Name: QSC 99% Peptides CAS 1415456-99-3 Sema Tirz Retatrutide Weight Loss Cagrilintide
Brand: QSC=Qingdao Sigma Chemical
SKU: pr2408081293
Price: 3.06 USD
Availability: InStock

66 Inquiries

Unit Price: Get Latest Price 

CAS No.:

1415456-99-3

Grade:

Pharmaceutical Grade

Content:

99%

Port:

QINGDAO

Brand:

QSC=Qingdao Sigma Chemical

Packaging:

25kg drum

Sample Available:

Yes

Price valid (until):

2024-11-14

Contact Supplier

 Chat Now

QIngdao Sigma Chemical Co.,Ltd

Company Type:

Trader

Location:

China

Payment Terms:

100% TT in advance

Average Lead Time:

1 days

Qualification:

Main Products:

bodybuilding Peptide,Steroids,Tirzepatide,semaglutide,Sarms

 Visit Store

Product Description
Seller Information
Inquiry History

Description

Shop Customized Content Ara-290 Chinese Factory CAS1208243-50-8-Detailed Image 1 Product Detail

Cagrilintide is an amylin-analog, now being developed in combination with the GLP-1 agonist semaglutide to achieve sustained weight loss in persons with overweight and obesity. Amylin, released with insu from beta cells in the pancreas, induces its satiating effect via both the homoeostatic and hedonic regions of the brain. Semaglutide, a GLP-1 receptor agonist, reduces appetite via GLP-1 receptors in the hypothalamus and increases the production of insu, and reduces glucagon secretion, delaying gastric emptying. These separate, but related mechanisms of action of an amylin-analog and a GLP-1 receptor agonist appear to have an additive effect on appetite reduction. Given the heterogeneity and complex pathogenesis of obesity, combination therapy with multiple pathophysiological targets is a logical approach to increasing weight loss response with pharmacotherapy. Cagrilintide alone, as well as cagrilintide in combination with semaglutide have shown promising weight loss in clinical trials that supports the further development of this therapy for sustained weight management.

GENERIC PEPTIDES LIST:

Product	Sequence	Therapeutic Area	Form	Unit Size
Semaglutide CAS No.: 910463-68-2	H-His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(AEEAc-AEEAc-γ-Glu-carboxyheptadecanoyl)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-OH	Type II diabetes mellitus Obesity	Lyophilized powder	2 mg/vial 5 mg/vial 10 mg/vial 15 mg/vial 20 mg/vial
Tirzepatide CAS No.: 2023788-19-2	H-Tyr-{Aib}-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-{Aib}-Leu-Asp-Lys-Ile-Ala-Gln-{diacid-gamma-Glu-(AEEA)2-Lys}-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2	Type II diabetes mellitus Obesity	Lyophilized powder	10 mg/vial 15 mg/vial 20 mg/vial 30 mg/vial 60 mg/vial
Cagrilintide CAS No.: 1415456-99-3	{Eicosanedioic acid-γ-Glu}-Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Glu-Phe-Leu-Arg-His-Ser-Ser-Asn-Asn-Phe-Gly-Pro-Ile-Leu-Pro-Pro-Thr-Asn-Val-Gly-Ser-Asn-Thr-Pro-NH2	Type II diabetes mellitus Obesity	Lyophilized powder	5 mg/vial 10 mg/vial
CagriSema	Blend	Type II diabetes mellitus Obesity	Lyophilized powder	5 mg/vial 10 mg/vial 20 mg/vial
Retatrutide CAS No. 2381089-83-2	Tyr-{Aib}-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-{α-Me-Leu}-Leu-Asp-Lys-{diacid-C20-gamma-Glu-(AEEA)-Lys}-Ala-Gln-{Aib}-Ala-Phe-Ile-Glu-Tyr-Leu-Leu-Glu-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2	Treatment of type 2 diabetes Treatment of obesity	Lyophilized powder	8 mg/vial 10 mg/vial 12 mg/vial 15 mg/vial 30 mg/vial

Shop Customized Content Ara-290 Chinese Factory CAS1208243-50-8-Detailed Image 2

Shop QSC 99% Peptides CAS 1415456-99-3 Sema Tirz Retatrutide Weight Loss Cagrilintide-Detailed Image 5

Q: Can I get free samples?

A: Sure, we can provide a free sample, but the shipping cost will be paid by the customers.

Q: How to make payment?

A: All Kinds of payment method

Q: How to delivery?

A: Parcel will be shipped out in 2 workdays after payment, usually via FedEx, EMS, HKEMS, DHL, TNT, USPS Domestic fast shipping, signature not requested.

Q: Is there any discount?

A: Yes.The price is negotiable, just send us the quantity of items you need, we will apply you the best price and discount.

Q: What is the Minimum order quantity?

A: peptide minimum is 1 box

ECHEMI Editorial Reference

Cagrilintide is a long-acting amylin analog and peptide-based pharmaceutical ingredient. As a pharmaceutical raw material, Cagrilintide is characterized by its peptide structure and amylin receptor activity. It is suitable for API research, analytical testing, pharmaceutical development, and related manufacturing processes.

Basic Info

Product Name:

Cagrilintide

Other Name:

‌Cagrilitide、Cagrilintide acetate、Caglitide、Kagliptin、Cargliptin、Cargilinitide

CAS No.:

1415456-99-3

Molecular Formula:

C194H312N54O59S2

Molecular Weight:

EC Number:

206-141-6

Color/Form:

White to off-white

Categories:

Polypeptide

Research

Class:

Amylin receptor (AMYR) / calcitonin receptor (CTR) agonist (long-acting amylin analog)

Status:

Investigational — Phase 3 (REDEFINE program, CagriSema combination)

Mechanism:

A novel long-acting, acylated amylin (islet amyloid polypeptide, IAPP) analog consisting of 38 amino acids. Cagrilintide activates the amylin receptor (AMYR) and calcitonin receptor (CTR), reducing food intake, delaying gastric emptying, and promoting satiety. Being developed as monotherapy and in fixed-dose combination with semaglutide (CagriSema) for obesity.

Activity note:

Cagrilintide is a non-selective AMYR/CTR agonist. Specific EC50 values not publicly available; functional potency is comparable to native amylin at AMYR.

Source:

MCE: Cagrilintide (CAS 1415456-99-3); Novo Nordisk REDEFINE program.

Clinical Development:

NCT05249895; NCT05249882

References

PubChem:

PubChem

Literature:

MCE: Cagrilintide (CAS 1415456-99-3); ClinicalTrials.gov: REDEFINE-1 (NCT05249895); Novo Nordisk: EASD 2025 Cagrilintide data presentation

Disclaimer:

Cagrilintide is NOT FDA-approved or EMA-approved. It is in Phase 3 clinical trials (REDEFINE program). This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

Seller Information

Business Type:
Trader

Main Products:
bodybuilding Peptide,Steroids,Tirzepatide,semaglutide,Sarms

Location:
NO 40 shandong Road,Shibei District, Qingdao City,Shandong Province

Payment Terms:
100% TT in advance

Average lead Time:
1 days

Total Annual Revenue:
$25 million-$50 million

Total Employees:
51-100

Year of Establishment:
2017

Company Certificates
- COA

Inquiry History

66 Inquiries

Country	Product	Purchase Quantity	Date Posted
United States	Cagrilintide	20 MG	Sep 30, 2026
Australia	Cagrilintide	20 MG	Aug 17, 2026
United Kingdom	Cagrilintide	10 MG	Jul 31, 2026
France	Cagrilintide	10 MG	May 22, 2026
Australia	Cagrilintide	4 MT	Mar 9, 2026
United States	Cagrilintide	15 MG	Feb 25, 2026
United States	Cagrilintide	10 PCS	Dec 27, 2025
United States	Cagrilintide	2 MT	Dec 21, 2025
United States	Cagrilintide	100 MG	Oct 28, 2025
United States	cagrilintide	2 MT	Aug 8, 2025
Philippines	Retatrutide	5 MG	Aug 5, 2025
China	Cagrilintide	100 G	May 6, 2025
United States	cagrilintide	5 MG	Feb 18, 2025
United States	Cagrilintide	3 MT	Feb 7, 2025
United States	Cagrilintide	100	Nov 12, 2024
United States	Cagrillintide Lyophilized powder	100 MG	Jul 4, 2024
United States	Cagrillintide Lyophilized powder	1000 MG	Apr 20, 2024
United States	Cagrilintide	10 MG	Sep 23, 2026
United States	Cagrilintide	25 MG	Aug 31, 2026
United States	Cagrlintide	1 MT	Jul 31, 2026

Go to Page

Post an enquiry for this product

More Choices Find All Products for Sale 

Product Name	Grade / Content	Price	Supplier Name	Details
Cagrilintide Peptides 99% purity Weight Loss Peptide 10mg 15mg 30mg Fast Shipping	Pharmaceutical Grade/99	$2/G FOB	Yingtai Technology Co., Ltd	Inquiry
99% purity Cagrilintide Peptides Weight Loss Peptide 10mg Fast Shipping	Pharmaceutical Grade/99	$170-200/UNIT FOB	changxiaokeji	Inquiry
Cagrilintide CAS 1415456-99-3 99% Purity Lyophilized Powder Weight Loss PeptideBulk Stock Cagrilintide 99% Purity Pharmaceutical Intermediate	Pharmaceutical Grade/99	$20-22/MT FOB	LingMi BioTechnology Co., Ltd	Inquiry
CGL10 CGL10 High-quality peptides,white powder//provide home deliveryservice-available in stock in the warehouse99% purity + perfect after-sales servi	Research Grade/99	$30-35/UNIT FOB	Yiwu Nianwu	Inquiry
Wholesale 99%+ purity weight loss peptide Cagrilintide bulk raw CAS 1415456-99-3	Pharmaceutical Grade/99	$1/G FOB	Hubei Meisang Trading Co.,Ltd	Inquiry

QSC 99% Peptides CAS 1415456-99-3 Sema Tirz Retatrutide Weight Loss Cagrilintide

Product Description

Seller Information

Inquiry History

More Choices Find All Products for Sale 

Related Searches

More from this Seller